NuVasive, which recently merged with Globus Medical, launched its Precice bone treansport system in global markets, according to a Sept. 7 news release.
Precice is CE-marked and approved in other select markets. It is a less invasive product and has been used in more than 250 trauma and oncology patients.
"Multiple patients of mine have already benefitted from the all-internal, Precice Bone Transport system," Dr. Thomas Kern, an orthopedic surgeon in Germany, said in the release. "Being able to utilize the reliable Precice magnetic technology and treat more patients without the need for external fixation or amputation, is something I’m proud to be a part of."